Presentation TCT 2012 The European TAVR “Test Track”: After 5 Years, Have TAVR Use Patterns Drifted Out of Control? Presenter: Nicolo Piazza October 25, 2012
Presentation TCT 2012 Genetic Testing for 9p21: The Case for Health Care Insurance Reimbursement Presenter: H. Robert Superko October 25, 2012
Presentation TCT 2012 Glycoprotein IIb/IIIa Inhibitors in the Era of Bivalirudin and New Oral Antiplatelet Agents: Is Intracoronary Application the Standard of Choice? Presenter: Rajesh Dave October 25, 2012
Presentation TCT 2012 Managing a Peripheral Coronary Perforation Presenter: Koen Teeuwen October 25, 2012
Presentation TCT 2012 Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI! Presenter: Roxana Mehran October 25, 2012
Presentation TCT 2012 A Chilled Triple Dissection, It's Not a Drink! Presenter: Ulf Jensen October 25, 2012
Presentation TCT 2012 The Final Word: Neither IVUS nor FFR Explain It All—Use Common Sense! Presenter: Jeffrey Moses October 25, 2012